CVS Health Co. (NYSE:CVS) Shares Sold by MONECO Advisors LLC

MONECO Advisors LLC trimmed its holdings in shares of CVS Health Co. (NYSE:CVS) by 4.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 18,712 shares of the pharmacy operator’s stock after selling 816 shares during the period. MONECO Advisors LLC’s holdings in CVS Health were worth $840,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of CVS. AMF Tjanstepension AB raised its holdings in shares of CVS Health by 124.1% during the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock worth $3,882,000 after purchasing an additional 34,198 shares during the period. International Assets Investment Management LLC increased its holdings in shares of CVS Health by 8,947.4% in the 3rd quarter. International Assets Investment Management LLC now owns 1,145,849 shares of the pharmacy operator’s stock worth $72,051,000 after acquiring an additional 1,133,184 shares during the period. Silver Oak Securities Incorporated increased its holdings in shares of CVS Health by 65.7% in the 3rd quarter. Silver Oak Securities Incorporated now owns 6,379 shares of the pharmacy operator’s stock worth $392,000 after acquiring an additional 2,530 shares during the period. Joel Isaacson & Co. LLC increased its holdings in shares of CVS Health by 57.6% in the 3rd quarter. Joel Isaacson & Co. LLC now owns 5,473 shares of the pharmacy operator’s stock worth $344,000 after acquiring an additional 2,000 shares during the period. Finally, Allworth Financial LP increased its holdings in shares of CVS Health by 10.7% in the 3rd quarter. Allworth Financial LP now owns 17,613 shares of the pharmacy operator’s stock worth $1,108,000 after acquiring an additional 1,706 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Michael F. Mahoney bought 30,000 shares of the firm’s stock in a transaction on Tuesday, February 18th. The stock was bought at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the acquisition, the director now directly owns 39,356 shares in the company, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.24% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. UBS Group dropped their price objective on shares of CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a report on Tuesday, February 11th. Leerink Partnrs raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 12th. TD Cowen increased their price objective on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. Wells Fargo & Company increased their target price on shares of CVS Health from $68.00 to $73.00 and gave the company an “overweight” rating in a research report on Thursday, February 13th. Finally, Piper Sandler decreased their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research report on Monday, November 25th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $70.00.

CVS Health Stock Performance

NYSE:CVS opened at $63.42 on Monday. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The company has a 50-day moving average of $52.39 and a 200-day moving average of $56.20. The firm has a market cap of $79.95 billion, a price-to-earnings ratio of 17.33, a price-to-earnings-growth ratio of 0.98 and a beta of 0.61.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.19%. The ex-dividend date was Thursday, January 23rd. CVS Health’s payout ratio is 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.